Mesenteric Tumor of an Infant: A Clinical and Pathological Surprise
DOI:
https://doi.org/10.21276/apalm.3143Keywords:
Anaplastic lymphoma kinase-1, colon, inflammatory myofibroblastic tumor, mesenteryAbstract
Inflammatory myofibroblastic tumor (IMT) is a tumefactive proliferation of spindled myofibroblastic cells admixed with inflammatory infiltrate. This tumor has a predilection for pulmonary location and also involves visceral soft tissues in children and adults. Tumors in extrapulmonary locations like abdomen, mesentery, bowel, head & neck, genitourinary and musculoskeletal are more aggressive locally and mimic malignancy. IMTs from colon are very rare and are treated by surgical excision. We report a case of a 9-month old female with IMT of sigmoid colon with no bowel complaints, treated by complete surgical excision with no further treatment needed.
References
Saxena S, Dhal I, Mohanpuria A, Garg J, Karnik S, Khedkar B. Extrapulmonary inflammatory myofibroblastic tumor at different sites with histopathology and immunohistochemical analysis: A case series. Oncol J India 2018;2:80-85
Camela F, Gallucci M, di Palmo E, et al. Pulmonary Inflammatory Myofibroblastic Tumor in Children: A Case Report and Brief Review of Literature. Front Pediatr. 2018;6:35.
Meis JM, Enzinger FM. Inflammatory fibrosarcoma of the mesentery and retroperitoneum. A tumor closely simulating inflammatory pseudotumor. Am J Surg Pathol. 1991;15:1146-1156.
Fletcher CD, Bridge JA, Hogendoorn P, Mertens F. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC Press, 2013; 83–84.
Cook JR, Dehner LP, Collins MH, et al. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol. 2001; 25:1364-1371.
Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007; 31: 509–520.
Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995;19(8):859-872.
Tao YL, Wang ZJ, Han JG, Wei P. Inflammatory myofibroblastic tumor successfully treated with chemotherapy and nonsteroidals: a case report. World J Gastroenterol. 2012; 18: 7100–7103.
Alaggio R, Cecchetto G, Bisogno G, et al. Inflammatory myofibroblastic tumors in childhood: a report from the Italian Cooperative Group studies. Cancer. 2010; 116:216-226.
Ogata M, Hatachi Y, Ogata T, Satake H, Imai Y, Yasui H. Effectiveness of crizotinib for inflammatory myofibroblastic tumor with ALK mutation. Intern Med. 2019; 58:1029-1032.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Md Ali Osama, Smita Singh, Sahaj Prajapati, Subhasis Roy Choudhury, Nishat Amina
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
